[go: up one dir, main page]

NO20050047L - Osmotisk avleveringssystem med tidlig, nulte-ordens skyvekraftmotor omfattende et osmotisk middel dispergert i den fluide baereren - Google Patents

Osmotisk avleveringssystem med tidlig, nulte-ordens skyvekraftmotor omfattende et osmotisk middel dispergert i den fluide baereren

Info

Publication number
NO20050047L
NO20050047L NO20050047A NO20050047A NO20050047L NO 20050047 L NO20050047 L NO 20050047L NO 20050047 A NO20050047 A NO 20050047A NO 20050047 A NO20050047 A NO 20050047A NO 20050047 L NO20050047 L NO 20050047L
Authority
NO
Norway
Prior art keywords
osmotic
delivery system
early
zero
fluid carrier
Prior art date
Application number
NO20050047A
Other languages
English (en)
Inventor
Stephen A Berry
Pamela J Fereira
Original Assignee
Alza Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alza Corp filed Critical Alza Corp
Publication of NO20050047L publication Critical patent/NO20050047L/no

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4808Preparations in capsules, e.g. of gelatin, of chocolate characterised by the form of the capsule or the structure of the filling; Capsules containing small tablets; Capsules with outer layer for immediate drug release
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0002Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0004Osmotic delivery systems; Sustained release driven by osmosis, thermal energy or gas
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue

Landscapes

  • Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Det er beskrevet en osmotisk motor som er nyttig i et osmotisk avleveringssystem for avlevering av et fordelaktig middel på en kontrollert måte over en på forhånd valgt administrasjonsperiode. Ved å innbefatte en flytbar motor omfattende minst ett osmotisk middel og minst en fiuidvehikkel når den resulterende osmotiske motoren nulte ordens skyvekraft eller skyverate raskt å tilveiebringe jevn avlevering av det fordelaktige middelet.
NO20050047A 2002-06-17 2005-01-05 Osmotisk avleveringssystem med tidlig, nulte-ordens skyvekraftmotor omfattende et osmotisk middel dispergert i den fluide baereren NO20050047L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US38950902P 2002-06-17 2002-06-17
PCT/US2003/018953 WO2003105803A1 (en) 2002-06-17 2003-06-17 Osmotic delivery system with early zero order push power engine comprising an osmotic agent dispersed in the fluid vehicle

Publications (1)

Publication Number Publication Date
NO20050047L true NO20050047L (no) 2005-01-05

Family

ID=29736646

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20050047A NO20050047L (no) 2002-06-17 2005-01-05 Osmotisk avleveringssystem med tidlig, nulte-ordens skyvekraftmotor omfattende et osmotisk middel dispergert i den fluide baereren

Country Status (19)

Country Link
US (2) US7074423B2 (no)
EP (1) EP1536767B1 (no)
JP (1) JP2005533782A (no)
KR (1) KR20050026402A (no)
CN (1) CN1668279A (no)
AR (1) AR039696A1 (no)
AT (1) ATE369119T1 (no)
AU (1) AU2003251535B2 (no)
BR (1) BR0311897A (no)
CA (1) CA2489325C (no)
DE (1) DE60315474T2 (no)
IL (1) IL165697A (no)
MX (1) MXPA04012976A (no)
MY (1) MY135711A (no)
NO (1) NO20050047L (no)
NZ (1) NZ537136A (no)
TW (1) TW200420306A (no)
WO (1) WO2003105803A1 (no)
ZA (1) ZA200500343B (no)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MY125870A (en) * 1997-07-25 2006-08-30 Alza Corp Osmotic delivery system flow modulator apparatus and method
US7258869B1 (en) * 1999-02-08 2007-08-21 Alza Corporation Stable non-aqueous single phase viscous vehicles and formulations utilizing such vehicle
US7919109B2 (en) 1999-02-08 2011-04-05 Intarcia Therapeutics, Inc. Stable non-aqueous single phase viscous vehicles and formulations utilizing such vehicles
US7163688B2 (en) * 2001-06-22 2007-01-16 Alza Corporation Osmotic implant with membrane and membrane retention means
ATE369119T1 (de) * 2002-06-17 2007-08-15 Alza Corp Osmotisches abgabesystem mit schubmotor früher nullter ordnung mit einem osmotischen mittel, das in dem flüssigen vehikel dispergiert ist
US7731947B2 (en) * 2003-11-17 2010-06-08 Intarcia Therapeutics, Inc. Composition and dosage form comprising an interferon particle formulation and suspending vehicle
JP2006512370A (ja) * 2002-12-19 2006-04-13 アルザ・コーポレーション 安定な非水性単相ゲル、および植込み型デバイスから送達するためのその配合物
WO2004089334A2 (en) * 2003-03-31 2004-10-21 Alza Corporation Osmotic delivery system and method for decreasing start-up times for osmotic delivery systems
EP1613389B8 (en) * 2003-03-31 2008-05-07 Intarcia Therapeutics, Inc. Osmotic pump with means for dissipating internal pressure
JP2007526792A (ja) * 2003-11-06 2007-09-20 アルザ・コーポレーシヨン 移植可能な浸透ポンプと一緒の使用のためのモジュール型の吸入速度低下器
US20050266087A1 (en) * 2004-05-25 2005-12-01 Gunjan Junnarkar Formulations having increased stability during transition from hydrophobic vehicle to hydrophilic medium
WO2006083761A2 (en) 2005-02-03 2006-08-10 Alza Corporation Solvent/polymer solutions as suspension vehicles
US8052996B2 (en) * 2005-02-03 2011-11-08 Intarcia Therapeutics, Inc. Two-piece, internal-channel osmotic delivery system flow modulator
US11246913B2 (en) 2005-02-03 2022-02-15 Intarcia Therapeutics, Inc. Suspension formulation comprising an insulinotropic peptide
US20060263433A1 (en) * 2005-02-03 2006-11-23 Ayer Rupal A Suspension formulation of interferon
US7959938B2 (en) 2005-03-15 2011-06-14 Intarcia Therapeutics, Inc. Polyoxaester suspending vehicles for use with implantable delivery systems
PT2359808E (pt) 2006-08-09 2013-08-28 Intarcia Therapeutics Inc Sistemas de entrega osmótica e montagens de pistão
PL2157967T3 (pl) 2007-04-23 2013-06-28 Intarcia Therapeutics Inc Formulacje zawiesinowe peptydów insulinotropowych i ich zastosowania
CA2726861C (en) 2008-02-13 2014-05-27 Intarcia Therapeutics, Inc. Devices, formulations, and methods for delivery of multiple beneficial agents
US20090259112A1 (en) * 2008-04-09 2009-10-15 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Sensors
US20090259217A1 (en) * 2008-04-09 2009-10-15 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Methods and systems associated with delivery of one or more agents to an individual
NZ592113A (en) * 2008-10-15 2012-04-27 Intarcia Therapeutics Inc Highly concentrated drug particles, formulations, suspensions and uses thereof
HUE035862T2 (en) 2009-09-28 2018-05-28 Intarcia Therapeutics Inc Rapid establishment and/or termination of substantial steady-state drug delivery
CN101897995B (zh) * 2010-07-09 2012-12-19 深圳市北科生物科技有限公司 一种可植入的披膜三维载体及其制备方法
SG188317A1 (en) 2010-08-30 2013-04-30 Sinusys Corp Devices for dilating a paranasal sinus opening and for treating sinusitis
US8518440B2 (en) 2010-12-21 2013-08-27 Confluent Surgical, Inc. Biodegradable osmotic pump implant for drug delivery
US20120208755A1 (en) 2011-02-16 2012-08-16 Intarcia Therapeutics, Inc. Compositions, Devices and Methods of Use Thereof for the Treatment of Cancers
US8979885B2 (en) 2012-02-24 2015-03-17 Elwha Llc Devices, systems, and methods to control stomach volume
CA2862297A1 (en) 2012-02-29 2013-09-06 SinuSys Corporation Devices and methods for dilating a paranasal sinus opening and for treating sinusitis
US9687263B2 (en) 2013-05-30 2017-06-27 SinuSys Corporation Devices and methods for inserting a sinus dilator
US9889085B1 (en) 2014-09-30 2018-02-13 Intarcia Therapeutics, Inc. Therapeutic methods for the treatment of diabetes and related conditions for patients with high baseline HbA1c
MX2017015504A (es) 2015-06-03 2018-05-15 Intarcia Therapeutics Inc Sistemas de colocacion y remoción de implante.
CA3024479A1 (en) 2016-05-16 2017-11-23 Intarcia Therapeutics, Inc. Glucagon-receptor selective polypeptides and methods of use thereof
USD840030S1 (en) 2016-06-02 2019-02-05 Intarcia Therapeutics, Inc. Implant placement guide
USD860451S1 (en) 2016-06-02 2019-09-17 Intarcia Therapeutics, Inc. Implant removal tool
CN110225762A (zh) 2017-01-03 2019-09-10 因塔西亚制药公司 包括glp-1受体激动剂的连续施用和药物的共同施用的方法
USD933219S1 (en) 2018-07-13 2021-10-12 Intarcia Therapeutics, Inc. Implant removal tool and assembly
CN110613872A (zh) * 2019-10-31 2019-12-27 厦门大学嘉庚学院 一种防止血液凝固的留置针辅助装置及其工作方法

Family Cites Families (48)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4034756A (en) * 1971-01-13 1977-07-12 Alza Corporation Osmotically driven fluid dispenser
JPS5854962A (ja) * 1981-09-27 1983-04-01 テルモ株式会社 注出ポンプ
US4783337A (en) * 1983-05-11 1988-11-08 Alza Corporation Osmotic system comprising plurality of members for dispensing drug
US4851228A (en) * 1984-06-20 1989-07-25 Merck & Co., Inc. Multiparticulate controlled porosity osmotic
US4624847A (en) * 1985-04-22 1986-11-25 Alza Corporation Drug delivery device for programmed delivery of beneficial drug
US4609374A (en) * 1985-04-22 1986-09-02 Alza Corporation Osmotic device comprising means for governing initial time of agent release therefrom
US4874388A (en) * 1987-06-25 1989-10-17 Alza Corporation Multi-layer delivery system
US5938654A (en) * 1987-06-25 1999-08-17 Alza Corporation Osmotic device for delayed delivery of agent
US5023088A (en) * 1987-06-25 1991-06-11 Alza Corporation Multi-unit delivery system
US4886668A (en) * 1987-09-24 1989-12-12 Merck & Co., Inc. Multiparticulate controlled porosity osmotic pump
US5223266A (en) 1990-01-24 1993-06-29 Alza Corporation Long-term delivery device with early startup
US5324280A (en) * 1990-04-02 1994-06-28 Alza Corporation Osmotic dosage system for delivering a formulation comprising liquid carrier and drug
AU2867492A (en) * 1991-10-10 1993-05-03 Alza Corporation Osmotic drug delivery devices with hydrophobic wall materials
US5318780A (en) * 1991-10-30 1994-06-07 Mediventures Inc. Medical uses of in situ formed gels
US5209746A (en) * 1992-02-18 1993-05-11 Alza Corporation Osmotically driven delivery devices with pulsatile effect
US5639477A (en) * 1993-06-23 1997-06-17 Alza Corporation Ruminal drug delivery device
US5388883A (en) * 1993-11-18 1995-02-14 Yang; Shyue-Jong A. Sun shield cover
US5595759A (en) * 1994-11-10 1997-01-21 Alza Corporation Process for providing therapeutic composition
US5904935A (en) * 1995-06-07 1999-05-18 Alza Corporation Peptide/protein suspending formulations
EP0877599B1 (en) * 1996-02-02 2003-03-26 Alza Corporation Sustained delivery of leuprolide using an implantable system
US6132420A (en) 1996-02-02 2000-10-17 Alza Corporation Osmotic delivery system and method for enhancing start-up and performance of osmotic delivery systems
US5932547A (en) * 1996-07-03 1999-08-03 Alza Corporation Non-aqueous polar aprotic peptide formulations
ES2203824T3 (es) * 1996-11-15 2004-04-16 Alza Corporation Sistema de administracion osmotica y procedimiento para mejorar su arranque y funcionamiento.
ZA981610B (en) * 1997-03-24 1999-08-26 Alza Corp Self adjustable exit port.
MY125849A (en) * 1997-07-25 2006-08-30 Alza Corp Osmotic delivery system, osmotic delivery system semipermeable body assembly, and method for controlling delivery rate of beneficial agents from osmotic delivery systems
MY125870A (en) * 1997-07-25 2006-08-30 Alza Corp Osmotic delivery system flow modulator apparatus and method
EP1041975B1 (en) * 1997-12-22 2002-09-04 Alza Corporation Rate controlling membranes for controlled drug delivery devices
JP4173635B2 (ja) * 1997-12-29 2008-10-29 インターシア セラピューティクス,インコーポレイティド 膜プラグ保持機構を有する浸透供給装置
PT1736145E (pt) * 1997-12-30 2012-03-16 Intarcia Therapeutics Inc Sistema de entrega de agente benéfico com obturador de membrana
CA2356860C (en) * 1998-12-31 2006-11-07 Alza Corporation Osmotic delivery system having space efficient piston
US7258869B1 (en) * 1999-02-08 2007-08-21 Alza Corporation Stable non-aqueous single phase viscous vehicles and formulations utilizing such vehicle
ES2248156T3 (es) * 1999-12-21 2006-03-16 Alza Corporation Valvula para dispositivos osmoticos.
US7163688B2 (en) * 2001-06-22 2007-01-16 Alza Corporation Osmotic implant with membrane and membrane retention means
AR026386A1 (es) * 2001-10-24 2003-02-12 Massara Julio Eduardo Un dispositivo intravaginal que contiene progesterona, util como inductor de celo en bovinos productores de carne y leche, y el procedimiento paraprepararlo
ATE369119T1 (de) * 2002-06-17 2007-08-15 Alza Corp Osmotisches abgabesystem mit schubmotor früher nullter ordnung mit einem osmotischen mittel, das in dem flüssigen vehikel dispergiert ist
US7014636B2 (en) * 2002-11-21 2006-03-21 Alza Corporation Osmotic delivery device having a two-way valve and a dynamically self-adjusting flow channel
JP2006512370A (ja) * 2002-12-19 2006-04-13 アルザ・コーポレーション 安定な非水性単相ゲル、および植込み型デバイスから送達するためのその配合物
US7731947B2 (en) * 2003-11-17 2010-06-08 Intarcia Therapeutics, Inc. Composition and dosage form comprising an interferon particle formulation and suspending vehicle
EP1613389B8 (en) * 2003-03-31 2008-05-07 Intarcia Therapeutics, Inc. Osmotic pump with means for dissipating internal pressure
RU2005133427A (ru) * 2003-03-31 2006-04-27 Алза Корпорейшн (Us) Безводные однофазные носители и препараты с использованием таких носителей
US8377459B2 (en) * 2003-07-09 2013-02-19 The Procter & Gamble Company Composition for wet wipes that enhances the efficacy of cleansing while being gentle to the skin
US20050175701A1 (en) * 2004-02-10 2005-08-11 Alza Corporation Capillary moderator for osmotic delivery system
US20050266087A1 (en) * 2004-05-25 2005-12-01 Gunjan Junnarkar Formulations having increased stability during transition from hydrophobic vehicle to hydrophilic medium
US8052996B2 (en) * 2005-02-03 2011-11-08 Intarcia Therapeutics, Inc. Two-piece, internal-channel osmotic delivery system flow modulator
WO2006083761A2 (en) * 2005-02-03 2006-08-10 Alza Corporation Solvent/polymer solutions as suspension vehicles
US20060216242A1 (en) * 2005-02-03 2006-09-28 Rohloff Catherine M Suspending vehicles and pharmaceutical suspensions for drug dosage forms
US7959938B2 (en) * 2005-03-15 2011-06-14 Intarcia Therapeutics, Inc. Polyoxaester suspending vehicles for use with implantable delivery systems
US20070027105A1 (en) * 2005-07-26 2007-02-01 Alza Corporation Peroxide removal from drug delivery vehicle

Also Published As

Publication number Publication date
ATE369119T1 (de) 2007-08-15
AU2003251535A1 (en) 2003-12-31
EP1536767A1 (en) 2005-06-08
ZA200500343B (en) 2006-03-29
KR20050026402A (ko) 2005-03-15
US20060184158A1 (en) 2006-08-17
AU2003251535B2 (en) 2008-12-18
BR0311897A (pt) 2005-04-05
MXPA04012976A (es) 2005-05-16
MY135711A (en) 2008-06-30
US7074423B2 (en) 2006-07-11
CN1668279A (zh) 2005-09-14
CA2489325A1 (en) 2003-12-24
US20040097906A1 (en) 2004-05-20
TW200420306A (en) 2004-10-16
DE60315474T2 (de) 2008-04-24
EP1536767B1 (en) 2007-08-08
WO2003105803A1 (en) 2003-12-24
IL165697A0 (en) 2006-01-15
NZ537136A (en) 2007-07-27
CA2489325C (en) 2010-08-10
JP2005533782A (ja) 2005-11-10
IL165697A (en) 2010-04-29
AR039696A1 (es) 2005-03-09
DE60315474D1 (de) 2007-09-20

Similar Documents

Publication Publication Date Title
NO20050047L (no) Osmotisk avleveringssystem med tidlig, nulte-ordens skyvekraftmotor omfattende et osmotisk middel dispergert i den fluide baereren
BRPI0414907A (pt) formulações farmacêuticas com liberação sustentada injetáveis, orais ou tópicas
TR200001998T1 (tr) Kontrollü salıverilen tolterodin uygulamak için ilaç formülasyonu
BRPI0512991A (pt) uso de uma progestina, kit farmaceuticamente útil adaptado para a administração oral diária, e, método de contracepção em uma fêmea em idade de parto
BR9510452A (pt) Composição farmacêutica e aquosa estéril para a administração parenteral processos para limitar o potencial de crescimento microbiano em composição farmacêutica estéril para a administração parenteral para produzir anestesia em um animal de sangue quente e para aperfeiçoar o tempo de administração e/ou o tempo entre as trocas de conjuntos
ES2113346T3 (es) Metodo para potenciar el transporte de moleculas exogenas a traves de la membrana.
BR9906088A (pt) Válvula para acionamento de cilindros pneumáticos em geral
IL193639A (en) Purified collagen for use as a cellulite treatment drug
BR0106630A (pt) Sistema e processo para intervenção em um poço
PE20050438A1 (es) Formulas farmaceuticas, metodos y regimenes de dosificacion para el tratamiento y la prevencion de sindromes coronarios agudos
CL2010001484A1 (es) Uso de una composicion que contiene metilamida del acido 4[4-[3-(4-cloro-3-trifluorometilfenil)-ureido]-3-fluoro-fenoxi]-piridin-2-carboxilico, sales, hidratos o solvatos del mismo, dispersados dentro de una matriz solida, sola o en combinacion con otras terapias para tratar trastornos hiperproliferativos. (sol.div. 2173-2005).
MY137202A (en) System and method for a unified composition engine in a graphics processing system
DK1041967T3 (da) Mikropartikler og deres terapeutiske eller diagnostiske anvendelse
ATE357268T1 (de) Verriegelungssperre für eine verbindung von gehäuseabschnitten eines verabreichungsgeräts
BRPI0517577A (pt) montagem de bomba de medição para mesclar um agente de redução de fluido em um fluxo de gás de exaustão
DK1883387T3 (da) Beholder til flydende medikamenter, der skal administreres
NO964433D0 (no) Farmasöytiske preparater på basis av derivater av taxanklassen
AR010595A1 (es) Dispositivo osmotico para administrar drogas y metodo para mejorar el tiempo inicio del dispositivo
ATE348630T1 (de) Verminderung der nebenwirkungen der chemotherapie in krebspatienten
BRPI0407303A (pt) Composição farmacêutica
BR0315513A (pt) Composição farmacêutica injetável, processo para preparação de composição farmacêutica, e, uso de cefquinoma em um veìculo com liberação prolongada
BR0007458A (pt) Multiplicador de pressão para um sistema de injeção de combustìvel para motores de combustão interna
BRPI0511400A (pt) dispositivo para o estìmulo dos músculos do aparelho locomotor
DE502005002764D1 (de) Hydraulische lenkung mit absicherung gegen unkontrollierte lenkbewegungen
ES2164630T3 (es) Sistema combinado de varios aparatos medicos para anestesia total intravenosa.

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application